Match tier Listed
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-08-15

Sayed Aliul Hasan Abdi

Researcher

Also affiliated: JSS Academy of Higher Education and Research (2012); Karolinska University Hospital (2023); Qassim University (2017); University of Tennessee Health Science Center (2023); Hamdard University (2014–2015); Jamia Hamdard (2016–2020); University of Arkansas Medical Center (2025); Institute on Aging (2024–2026); Shaheed Rajaei Cardiovascular Medical and Research Center (2020); Al Baha University (2020–2026); Donaldson (United States) (2026)

Faculty Researcher

11 h-index 43 pubs 469 cited

  • Humans
  • Animals
  • Male
  • Mice
  • Molecular Docking Simulation
  • Oxidative Stress
  • Molecular Dynamics Simulation
  • Acute Kidney Injury
  • Chemical and Drug Induced Liver Injury
  • Adult
  • Female
  • Antioxidants
  • Bisphenol A Compounds
  • Benzhydryl Compounds
  • Phenols

Biography and Research Information

OverviewAI-generated summary

Sayed Aliul Hasan Abdi's research focuses on investigating the molecular mechanisms underlying various diseases and the potential therapeutic effects of compounds. His work utilizes computational approaches, including molecular docking and dynamics simulations, to screen and analyze the interactions between small molecules and biological targets. This approach has been applied to study the role of oxidative stress in acute kidney injury, the efficacy of resveratrol as a potential treatment, and the disruptive effects of environmental chemicals like hexaconazole on hormone biosynthesis and acetylcholinesterase activity.

Abdi has also explored the development of in silico vaccine candidates, as demonstrated by his work on a multi-epitope-based vaccine for monkeypox. His research further extends to identifying new therapeutic agents, such as morusflavone for prostate cancer by targeting CYP17A1. He has also examined adverse drug reactions, including trends in severe cutaneous adverse reactions to anti-seizure medications in Asian populations. His scholarly contributions include 43 publications with 451 citations and an h-index of 11.

Metrics

  • h-index: 11
  • Publications: 43
  • Citations: 469

Selected Publications

  • RETRACTED: Abdi et al. Duloxetine, an SNRI, Targets pSTAT3 Signaling: In-Silico, RNA-Seq and In-Vitro Evidence for a Pleiotropic Mechanism of Pain Relief. Int. J. Mol. Sci. 2025, 26, 10432 (2026)
    International Journal of Molecular Sciences DOI OpenAlex
  • RETRACTED: Duloxetine, an SNRI, Targets pSTAT3 Signaling: In-Silico, RNA-Seq and In-Vitro Evidence for a Pleiotropic Mechanism of Pain Relief (2025)
    International Journal of Molecular Sciences 6 citations DOI OpenAlex
  • Mitochondrial Dynamics in Aging Heart (2025)
    Biomedicines 8 citations DOI OpenAlex
  • Alternative Splicing of Serum Response Factor Reveals Isoform-Specific Remodeling in Cardiac Diseases (2025)
    Genes 3 citations DOI OpenAlex
  • The Long-Term Cardiovascular Risks of Duloxetine Use in Older Adults: A Retrospective Medical Record-Based Adverse Drug Reaction Assessment (2024)
    Journal of Clinical Medicine 8 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

10 Collaborators 2 Institutions 1 Country

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics